L Margolin1, M Feinmesser, E Hodak. Show Affiliations » 1. Department of Medicine, Hadassah University Hospital, State University of New York, Staten Island, NY, USA. leon3087@yahoo.com
Abstract
Entities: Disease
Mesh: See more » AgedAnti-Bacterial Agents/therapeutic useCefazolin/therapeutic useDiabetes Mellitus, Type 2/complicationsErysipelas/complicationsErysipelas/drug therapyFemaleHumansParaproteinemias/complicationsVasculitis, Leukocytoclastic, Cutaneous/complicationsVasculitis, Leukocytoclastic, Cutaneous/drug therapyVasculitis, Leukocytoclastic, Cutaneous/immunologyVasculitis, Leukocytoclastic, Cutaneous/pathology
Substances: See more » Anti-Bacterial AgentsCefazolin
Year: 2003 PMID: 12694499 DOI: 10.1046/j.1365-4362.2003.01707_3.x
Source DB: PubMed Journal: Int J Dermatol ISSN: 0011-9059 Impact factor: 2.736